{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37538515", "DateRevised": {"Year": "2023", "Month": "08", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "08", "Day": "02"}], "Language": ["eng"], "ELocationID": ["10.1039/d3ra04007k"], "Journal": {"ISSN": "2046-2069", "JournalIssue": {"Volume": "13", "Issue": "33", "PubDate": {"Year": "2023", "Month": "Jul", "Day": "26"}}, "Title": "RSC advances", "ISOAbbreviation": "RSC Adv"}, "ArticleTitle": "Identification of new theobromine-based derivatives as potent VEGFR-2 inhibitors: design, semi-synthesis, biological evaluation, and <i>in silico</i> studies.", "Pagination": {"StartPage": "23285", "EndPage": "23307", "MedlinePgn": "23285-23307"}, "Abstract": {"AbstractText": ["This study aimed to design anticancer theobromine derivatives inhibiting VEGFR-2. The new compounds were tested <i>in vitro</i> to evaluate their effectiveness against MCF-7 and HepG2 cancer cell lines. Among these compounds, 15a showed the highest cytotoxicity against HepG2, with an IC<sub>50</sub> value of 0.76 \u03bcM, and significant anti-proliferative effects on MCF-7, with an IC<sub>50</sub> value of 1.08 \u03bcM. Notably, the selectivity index of 15a against the two cancer cells was 98.97 and 69.64, respectively. Moreover, 15a demonstrated potent VEGFR-2 inhibitory activity (IC<sub>50</sub> = 0.239 \u03bcM). Further investigations revealed that 15a induced apoptosis in HepG2 cells, significantly increasing early-stage and late-stage apoptosis percentages from 3.06% and 0.71% to 29.49% and 9.63%, respectively. It also upregulated caspase-3 and caspase-9 levels by 3.45-fold and 2.37-fold, respectively compared to control HepG2 cells. Additionally, 15a inhibited the migration and wound healing ability of HepG2 cells. Molecular docking confirmed the binding affinities of the semi-synthesized compounds to VEGFR-2, consistent with <i>in vitro</i> results. Several computational analyses (DFT, MD simulations, MM-GBSA, PLIP, and essential dynamics) supported the stability of the 15a-VEGFR-2 complex. Overall, the biological and computational findings suggest that compound 15a could be a promising lead compound for the development of a novel apoptotic anticancer agent."], "CopyrightInformation": "This journal is \u00a9 The Royal Society of Chemistry."}, "AuthorList": [{"Identifier": ["0000-0002-6955-2263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University Cairo11884 Egypt Ibrahimeissa@azhar.edu.eg."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University Cairo11884 Egypt Ibrahimeissa@azhar.edu.eg."}], "LastName": "Yousef", "ForeName": "Reda G", "Initials": "RG"}, {"Identifier": ["0000-0003-0893-6703"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University Cairo11884 Egypt Ibrahimeissa@azhar.edu.eg."}], "LastName": "Elkady", "ForeName": "Hazem", "Initials": "H"}, {"Identifier": ["0000-0002-2546-8035"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University Riyadh 13713 Saudi Arabia."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University P.O. Box 84428 Riyadh 11671 Saudi Arabia."}], "LastName": "Alsfouk", "ForeName": "Aisha A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Department, Faculty of Science, New Valley University El-Kharja 72511 Egypt."}], "LastName": "Husein", "ForeName": "Dalal Z", "Initials": "DZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biophysics Department, Faculty of Science, Cairo University Cairo 12613 Egypt."}], "LastName": "Ibrahim", "ForeName": "Ibrahim M", "Initials": "IM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry and Biochemistry, University of Mississippi University MS 38677 USA."}, {"Identifier": [], "Affiliation": "Department of Agriculture Chemistry, Faculty of Agriculture, Damietta University Damietta Egypt."}], "LastName": "Elhendawy", "ForeName": "Mostafa A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry and Biochemistry, University of Mississippi University MS 38677 USA."}], "LastName": "Godfrey", "ForeName": "Murrell", "Initials": "M"}, {"Identifier": ["0000-0001-8566-1980"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University Cairo 11884 Egypt ametwaly@azhar.edu.eg."}, {"Identifier": [], "Affiliation": "Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City) Alexandria Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "RSC Adv", "NlmUniqueID": "101581657", "ISSNLinking": "2046-2069"}, "CoiStatement": "There are no conflicts of interest to declare."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bray F. Ferlay J. Soerjomataram I. Siegel R. L. Torre L. A. Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.", "ArticleIdList": ["30207593"]}, {"Citation": "Belal A. Abdel Gawad N. M. Mehany A. B. Abourehab M. A. Elkady H. Al-Karmalawy A. A. Ismael A. S. Design, synthesis and molecular docking of new fused 1 H-pyrroles, pyrrolo [3,2-d] pyrimidines and pyrrolo [3,2-e][1,4] diazepine derivatives as potent EGFR/CDK2 inhibitors. J. Enzyme Inhib. Med. Chem. 2022;37(1):1884\u20131902.", "ArticleIdList": ["PMC9272933", "35801486"]}, {"Citation": "Khalifa M. M. Al-Karmalawy A. A. Elkaeed E. B. Nafie M. S. Tantawy M. A. Eissa I. H. Mahdy H. A. Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies. J. Enzyme Inhib. Med. Chem. 2022;37(1):299\u2013314.", "ArticleIdList": ["PMC8667898", "34894955"]}, {"Citation": "DeVita Jr V. T. Chu E. A history of cancer chemotherapy. Cancer Res. 2008;68(21):8643\u20138653.", "ArticleIdList": ["18974103"]}, {"Citation": "Fidler I. J. Ellis L. M. Chemotherapeutic drugs\u2014more really is not better. Nat. Med. 2000;6(5):500\u2013502.", "ArticleIdList": ["10802697"]}, {"Citation": "Shah A. A. Kamal M. A. Akhtar S. Tumor angiogenesis and VEGFR-2: mechanism, pathways and current biological therapeutic interventions. Curr. Drug Metab. 2021;22(1):50\u201359.", "ArticleIdList": ["33076807"]}, {"Citation": "Elrazaz E. Z. Serya R. A. Ismail N. S. Albohy A. Abou El Ella D. A. Abouzid K. A. Discovery of potent thieno [2,3-d] pyrimidine VEGFR-2 inhibitors: Design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations. Bioorg. Chem. 2021;113:105019.", "ArticleIdList": ["34091286"]}, {"Citation": "Metwaly A. M. Lianlian Z. Luqi H. Deqiang D. Black ginseng and its saponins: Preparation, phytochemistry and pharmacological effects. Molecules. 2019;24(10):1856.", "ArticleIdList": ["PMC6572638", "31091790"]}, {"Citation": "Metwaly A. M. Ghoneim M. M. Eissa I. H. Elsehemy I. A. Mostafa A. E. Hegazy M. M. Afifi W. M. Dou D. Traditional ancient Egyptian medicine: A review. Saudi J. Biol. Sci. 2021;28(10):5823\u20135832.", "ArticleIdList": ["PMC8459052", "34588897"]}, {"Citation": "Newman D. J. Cragg G. M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 2016;79(3):629\u2013661.", "ArticleIdList": ["26852623"]}, {"Citation": "da Rosa R. Schenkel E. P. Bernardes L. S. C. Semisynthetic and newly designed derivatives based on natural chemical scaffolds: moving beyond natural products to fight Trypanosoma cruzi. Phytochem. Rev. 2020;19(1):105\u2013122."}, {"Citation": "S\u00e1nchez-Recillas A. Navarrete-V\u00e1zquez G. Hidalgo-Figueroa S. Rios M. Y. Ibarra-Barajas M. Estrada-Soto S. Semisynthesis, ex vivo evaluation, and SAR studies of coumarin derivatives as potential antiasthmatic drugs. Eur. J. Med. Chem. 2014;77:400\u2013408.", "ArticleIdList": ["24681028"]}, {"Citation": "Carla Cadon\u00e1 F. Kolinski Machado A. Farina Azzolin V. Barbisan F. Bortoluzzi Dornelles E. Glanzner W. Bayard Gon\u00e7alves P. D. Elias Assmann C. Esteves Ribeiro E. Beatrice M\u00e2nica da Cruz I. Guaran\u00e1 a caffeine-rich food increases oxaliplatin sensitivity of colorectal HT-29 cells by apoptosis pathway modulation. Anti-Cancer Agents Med. Chem. 2016;16(8):1055\u20131065.", "ArticleIdList": ["26673759"]}, {"Citation": "Sugimoto N. Miwa S. Katakura M. Matsuzaki K. Shido O. Tsuchiya H. Yachie A. Theobromine, the primary methylxanthine found in Theobroma cacao, inhibits malignant glioblastoma cell growth by negatively regulating Akt/mammalian target of rapamycin kinase (LB836) FASEB J. 2014;28:LB836.", "ArticleIdList": ["24547961"]}, {"Citation": "Barcz E. Sommer E. Sokolnicka I. Gawrychowski K. Roszkowska-Purska K. Janik P. Skopinska-R\u00f3zewska E. The influence of theobromine on angiogenic activity and proangiogenic cytokines production of human ovarian cancer cells. Oncol. Rep. 1998;5(2):517\u2013537.", "ArticleIdList": ["9468592"]}, {"Citation": "Gil M. Skopi\u0144ska-R\u00f3zewska E. Radomska D. Demkow U. Skurzak H. Rochowska M. Beuth J. Roszkowski K. Effect of purinergic receptor antagonists suramin and theobromine on tumor-induced angiogenesis in BALB/c mice. Folia Biol. 1993;39(2):63\u201368.", "ArticleIdList": ["7504997"]}, {"Citation": "Alanazi M. M. Mahdy H. A. Alsaif N. A. Obaidullah A. J. Alkahtani H. M. Al-Mehizia A. A. Alsubaie S. M. Dahab M. A. Eissa I. H. New bis ([1,2,4]triazolo)[4,3-a: 3\u2032,4\u2032-c] quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation. Bioorg. Chem. 2021;112:104949.", "ArticleIdList": ["34023640"]}, {"Citation": "Alanazi M. M. Elkady H. Alsaif N. A. Obaidullah A. J. Alkahtani H. M. Alanazi M. M. Alharbi M. A. Eissa I. H. Dahab M. A. New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies. RSC Adv. 2021;11(48):30315\u201330328.", "ArticleIdList": ["PMC9044819", "35493991"]}, {"Citation": "Yousef R. G. Sakr H. M. Eissa I. H. Mehany A. B. Metwaly A. M. Elhendawy M. A. Radwan M. M. ElSohly M. A. Abulkhair H. S. El-Adl K. New quinoxaline-2 (1 H)-ones as potential VEGFR-2 inhibitors: Design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations. New J. Chem. 2021;45(36):16949\u201316964.", "ArticleIdList": ["34175720"]}, {"Citation": "Adnane L. Trail P. A. Taylor I. Wilhelm S. M. Sorafenib (BAY 43-9006, Nexavar\u00ae), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature. Methods Enzymol. 2006;407:597\u2013612.", "ArticleIdList": ["16757355"]}, {"Citation": "Peng F.-W. Liu D.-K. Zhang Q.-W. Xu Y.-G. Shi L. VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016) Expert Opin. Ther. Pat. 2017;27(9):987\u20131004.", "ArticleIdList": ["28621580"]}, {"Citation": "Yousef R. G. Elwan A. Gobaara I. M. Mehany A. B. Eldehna W. M. El-Metwally S. A. Alsfouk B. A. Elkaeed E. B. Metwaly A. M. Eissa I. H. Anti-cancer and immunomodulatory evaluation of new nicotinamide derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: in vitro and in silico studies. J. Enzyme Inhib. Med. Chem. 2022;37(1):2206\u20132222.", "ArticleIdList": ["PMC9466619", "35980113"]}, {"Citation": "Yousef R. G. Ibrahim A. Khalifa M. M. Eldehna W. M. Gobaara I. M. Mehany A. B. Elkaeed E. B. Alsfouk A. A. Metwaly A. M. Eissa I. H. Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: Virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies. J. Enzyme Inhib. Med. Chem. 2022;37(1):1389\u20131403.", "ArticleIdList": ["PMC9116259", "35577416"]}, {"Citation": "Yousef R. G. Elkady H. Elkaeed E. B. Gobaara I. M. Al-Ghulikah H. A. Husein D. Z. Ibrahim I. M. Metwaly A. M. Eissa I. H. (E)-N-(3-(1-(2-(4-(2,2,2-Trifluoroacetamido) benzoyl) hydrazono) ethyl) phenyl) nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer Studies. Molecules. 2022;27(22):7719.", "ArticleIdList": ["PMC9697799", "36431818"]}, {"Citation": "Hou T. Zhu L. Chen L. Xu X. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies. J. Chem. Inf. Comput. Sci. 2003;43(1):273\u2013287.", "ArticleIdList": ["12546563"]}, {"Citation": "Husein D. Z. Hassanien R. Khamis M. Cadmium oxide nanoparticles/graphene composite: Synthesis, theoretical insights into reactivity and adsorption study. RSC Adv. 2021;11(43):27027\u201327041.", "ArticleIdList": ["PMC9037664", "35480026"]}, {"Citation": "Wang T. Husein D. Z. Novel synthesis of multicomponent porous nano-hybrid composite, theoretical investigation using DFT and dye adsorption applications: Disposing of waste with waste. Environ. Sci. Pollut. Res. 2023;30(4):8928\u20138955.", "ArticleIdList": ["35460480"]}, {"Citation": "Van de Loosdrecht A. Beelen R. Ossenkoppele G. Broekhoven M. Langenhuijsen M. A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J. Immunol. Methods. 1994;174(1\u20132):311\u2013320.", "ArticleIdList": ["8083535"]}, {"Citation": "Elkaeed E. B. Yousef R. G. Elkady H. Mehany A. B. Alsfouk B. A. Husein D. Z. Ibrahim I. M. Metwaly A. M. Eissa I. H. In silico, in vitro VEGFR-2 inhibition, and anticancer activity of a 3-(hydrazonomethyl) naphthalene-2-ol derivative. J. Biomol. Struct. Dyn. 2022:1\u201316.", "ArticleIdList": ["36184591"]}, {"Citation": "Eldehna W. M. El Hassab M. A. Elsayed Z. M. Al-Warhi T. Elkady H. Abo-Ashour M. F. Abourehab M. A. Eissa I. H. Abdel-Aziz H. A. Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4,5-dihydropyrazoles as anticancer agents with potential EGFR inhibitory activity. Sci. Rep. 2022;12(1):12821.", "ArticleIdList": ["PMC9329325", "35896557"]}, {"Citation": "Taghour M. S. Elkady H. Eldehna W. M. El-Deeb N. M. Kenawy A. M. Elkaeed E. B. Alsfouk A. A. Alesawy M. S. Metwaly A. M. Eissa I. H. Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: In-vitro anticancer evaluation and in-silico studies. J. Enzyme Inhib. Med. Chem. 2022;37(1):1903\u20131917.", "ArticleIdList": ["PMC9272924", "35801403"]}, {"Citation": "Elkaeed E. B. Yousef R. G. Elkady H. Gobaara I. M. Alsfouk A. A. Husein D. Z. Ibrahim I. M. Metwaly A. M. Eissa I. H. The assessment of anticancer and VEGFR-2 inhibitory activities of a new 1 H-indole derivative: In silico and in vitro approaches. Processes. 2022;10(7):1391."}, {"Citation": "Ma C. Taghour M. S. Belal A. Mehany A. B. Mostafa N. Nabeeh A. Eissa I. H. Al-Karmalawy A. A. Design and synthesis of new quinoxaline derivatives as potential histone deacetylase inhibitors targeting hepatocellular carcinoma: in silico, in vitro, and SAR studies. Front. Chem. 2021;9:725135.", "ArticleIdList": ["PMC8493129", "34631658"]}, {"Citation": "Elkaeed E. B. Yousef R. G. Khalifa M. M. Ibrahim A. Mehany A. B. Gobaara I. M. Alsfouk B. A. Eldehna W. M. Metwaly A. M. Eissa I. H. Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies. Molecules. 2022;27(19):6203.", "ArticleIdList": ["PMC9571953", "36234734"]}, {"Citation": "Alesawy M. S. Abdallah A. E. Taghour M. S. Elkaeed E. B. Eissa I. H. Metwaly A. M. In silico studies of some isoflavonoids as potential candidates against COVID-19 targeting human ACE2 (hACE2) and viral main protease (Mpro) Molecules. 2021;26(9):2806.", "ArticleIdList": ["PMC8126168", "34068579"]}, {"Citation": "Elkady H. Elwan A. El-Mahdy H. A. Doghish A. S. Ismail A. Taghour M. S. Elkaeed E. B. Eissa I. H. Dahab M. A. Mahdy H. A. New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies. J. Enzyme Inhib. Med. Chem. 2022;37(1):403\u2013416.", "ArticleIdList": ["PMC8725875", "34961427"]}, {"Citation": "Eissa I. H. Khalifa M. M. Elkaeed E. B. Hafez E. E. Alsfouk A. A. Metwaly A. M. In silico exploration of potential natural inhibitors against SARS-CoV-2 nsp10. Molecules. 2021;26(20):6151.", "ArticleIdList": ["PMC8539059", "34684735"]}, {"Citation": "Eissa I. H. Dahab M. A. Ibrahim M. K. Alsaif N. A. Alanazi A. Eissa S. I. Mehany A. B. Beauchemin A. M. Design and discovery of new antiproliferative 1,2,4-triazin-3 (2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site. Bioorg. Chem. 2021;112:104965.", "ArticleIdList": ["34020238"]}, {"Citation": "Abraham M. J. Murtola T. Schulz R. P\u00e1ll S. Smith J. C. Hess B. Lindahl E. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1:19\u201325."}, {"Citation": "Jo S. Cheng X. Islam S. M. Huang L. Rui H. Zhu A. Lee H. S. Qi Y. Han W. Vanommeslaeghe K. CHARMM-GUI PDB manipulator for advanced modeling and simulations of proteins containing nonstandard residues. Adv. Protein Chem. Struct. Biol. 2014;96:235\u2013265.", "ArticleIdList": ["PMC4739825", "25443960"]}, {"Citation": "Lee J. Cheng X. Jo S. MacKerell A. D. Klauda J. B. Im W. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. Biophys. J. 2016;110(3):641a.", "ArticleIdList": ["PMC4712441", "26631602"]}, {"Citation": "Tuccinardi T. What is the current value of MM/PBSA and MM/GBSA methods in drug discovery? Expert Opin. Drug Discovery. 2021;16(11):1233\u20131237.", "ArticleIdList": ["34165011"]}, {"Citation": "Vald\u00e9s-Tresanco M. S. Vald\u00e9s-Tresanco M. E. Valiente P. A. Moreno E. gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J. Chem. Theory Comput. 2021;17(10):6281\u20136291.", "ArticleIdList": ["34586825"]}, {"Citation": "Bouysset C. Fiorucci S. ProLIF: a library to encode molecular interactions as fingerprints. J. Cheminf. 2021;13:1\u20139.", "ArticleIdList": ["PMC8466659", "34563256"]}, {"Citation": "Salentin S. Schreiber S. Haupt V. J. Adasme M. F. Schroeder M. PLIP: fully automated protein\u2013ligand interaction profiler. Nucleic Acids Res. 2015;43(W1):W443\u2013W447.", "ArticleIdList": ["PMC4489249", "25873628"]}, {"Citation": "Tubiana T. Carvaillo J.-C. Boulard Y. Bressanelli S. TTClust: a versatile molecular simulation trajectory clustering program with graphical summaries. J. Chem. Inf. Model. 2018;58(11):2178\u20132182.", "ArticleIdList": ["30351057"]}, {"Citation": "Amadei A. Linssen A. B. Berendsen H. J. Essential dynamics of proteins. Proteins: Struct., Funct., Bioinf. 1993;17(4):412\u2013425.", "ArticleIdList": ["8108382"]}, {"Citation": "Papaleo E. Mereghetti P. Fantucci P. Grandori R. De Gioia L. Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case. J. Mol. Graphics Modell. 2009;27(8):889\u2013899.", "ArticleIdList": ["19264523"]}, {"Citation": "Maisuradze G. G. Leitner D. M. Free energy landscape of a biomolecule in dihedral principal component space: Sampling convergence and correspondence between structures and minima. Proteins: Struct., Funct., Bioinf. 2007;67(3):569\u2013578.", "ArticleIdList": ["17348026"]}, {"Citation": "Hess B. Similarities between principal components of protein dynamics and random diffusion. Phys. Rev. E: Stat. Phys., Plasmas, Fluids, Relat. Interdiscip. Top. 2000;62(6):8438.", "ArticleIdList": ["11138145"]}, {"Citation": "Elkaeed E. B. Yousef R. G. Elkady H. Gobaara I. M. Alsfouk B. A. Husein D. Z. Ibrahim I. M. Metwaly A. M. Eissa I. H. Design, synthesis, docking, DFT, MD simulation studies of a new nicotinamide-based derivative: In vitro anticancer and VEGFR-2 inhibitory effects. Molecules. 2022;27(14):4606.", "ArticleIdList": ["PMC9317904", "35889478"]}, {"Citation": "Elkaeed E. B. Eissa I. H. Elkady H. Abdelalim A. Alqaisi A. M. Alsfouk A. A. Elwan A. Metwaly A. M. A multistage in silico study of natural potential inhibitors targeting SARS-CoV-2 main protease. Int. J. Mol. Sci. 2022;23(15):8407.", "ArticleIdList": ["PMC9369012", "35955547"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "6", "Day": "14"}, {"Year": "2023", "Month": "7", "Day": "27"}, {"Year": "2023", "Month": "8", "Day": "4", "Hour": "6", "Minute": "44"}, {"Year": "2023", "Month": "8", "Day": "4", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "8", "Day": "4", "Hour": "4", "Minute": "3"}, {"Year": "2023", "Month": "8", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["37538515", "PMC10395314", "10.1039/d3ra04007k", "d3ra04007k"]}}], "PubmedBookArticle": []}